Coya Therapeutics (COYA) Earnings Analysis

Coya Therapeutics (COYA) next reports earnings on 2026-08-11, consensus EPS -0.36 USD. Last quarter (2026-03-16) it missed with EPS -0.34 USD vs -0.27251 USD est (-24.8%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -3.80.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does COYA next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.36 USD
Revenue estimate0.00B

COYA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-16-0.34 USD-0.27251 USD-24.8%Miss
2025-08-12-0.36 USD-0.22 USD-63.6%Miss
2025-03-18-0.18 USD-0.26 USD+30.8%Beat
2024-08-12-0.19 USD-0.14 USD-35.7%Miss

Beat rate: 1/4 (25%) over reported quarters with consensus data.

COYA valuation and analyst view

Trailing P/E-3.80
Trailing EPS-1.26276 USD
Price / book1.49
Dividend yield0.00%
Market cap0.08B
Analyst consensusBuy (5 buy / 0 hold / 0 sell)
Avg price target12 USD

Related research pages

Frequently asked questions

When is Coya Therapeutics (COYA)'s next earnings date?

Coya Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.36 USD and revenue estimate of 0.00B.

Did COYA beat earnings last quarter?

In its 2026-03-16 report, COYA posted EPS of -0.34 USD versus a -0.27251 USD estimate — a miss of 24.8%.

What is COYA's earnings track record?

Over the last 4 reported quarters with consensus data, COYA beat estimates 1 times (25%).

What is COYA's current P/E ratio and EPS?

COYA trades at a trailing P/E of -3.80 on trailing EPS of -1.2627611478449188 USD.

What do analysts rate COYA?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 12 USD.